M. J. Duffy

Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1

Bríd M. Ryan, G. Konecny, Steffen Kahlert et al. · Annals of Oncology · 2006 · 158 citations · Full text

Urokinase Plasminogen Activator, Breast Oncology, Oncology +9

Smoking habits of long-term survivors of surgery for lung cancer.

Aidan Davison, M. J. Duffy · Thorax · 1982 · 65 citations · Full text

Tobacco Cessation, Surgical Oncology, Cancer Management +19

Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.

M. M. Skelly, A. Troy, M. J. Duffy et al. · PubMed · 1997 · 55 citations

Tumor Biology, Surgical Oncology, Urology +12

Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings

M. J. Duffy, J.P. Brouillet, David Reilly et al. · Clinical Chemistry · 1991 · 54 citations

Tumor Biology, Cathepsin D, Lysosomal Protease +14

Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients

Radka Saldova, Umi Marshida Abd Hamid, Jodie L. Abrahams et al. · Glycobiology · 2010 · 43 citations · Full text

Breast Oncology, Glycosylation, Cancer Detection +14